When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
Bristol-Myers Squibb Company
No matter how you look at it, Bristol-Myers Squibb(NYSE: BMY) claims an attractive dividend. Its yield currently stands north of 2.8%. The big pharma company has a payout ratio of only 47%, giving it plenty of flexibility to keep the solid dividends coming.
And Bristol-Myers Squibb's dividend now looks even better. Celgene(NASDAQ: CELG) just announced a key regulatory approval that should boost BMS' fortunes.